• October 2020
    FOCIS 2020
    Purvi Mande, Daniel Rios, Susmita Borthakur, Angela Boisvert, Michael Rowe, Patrick Halvey, Joanne L. Viney, Kata-Kis-Toth, Ivan Mascanfroni, Nathan Higginson-Scott, Kevin L. Otipoby
  • October 2020
    FOCIS 2020
    Patrick J. Halvey, Emily B. Lurier, Michael Cianci, Joanne L. Viney, Kevin L. Otipoby, Katalin Kis-Toth
  • October 2020
    FOCIS 2020
    Lindsay J. Edwards, Bridget Larkin, Salvatore Alioto, David Cluckey, Daniel C. Rios, Emily Lurier, Patrick Halvey, Katalin Kis-Toth, Nathan Higginson-Scott, Joanne L. Viney, Kevin L. Otipoby
  • October 2020
    FOCIS 2020
    Bilian Li, Bridget Larkin, Timothy Kiprono, Michael Rowe, Jyothsna Visweswaraiah, Nicola Willardsen, Jordan Allen, Kevin L. Otipoby, Joanne Viney, Hussam H. Shaheen and Nathan Higginson-Scott
  • May 2020
    PT101: A Treg selective agonist IL-2 mutein therapy for autoimmunity
    American Association of Immunologists Annual Meeting
    Nathan Higginson-Scott, Kevin L. Otipoby and Jo Viney
  • March 2020
    Discovery and Characterization of Tissue-Tethered PD-1 Agonist Antibodies
    Keystone T Cell Memory
    Bridget Larkin, Lindsay J. Edwards, Daniel C. Rios, Salvatore Alioto, Timothy Kiprono, Nathan Higginson-Scott, Joanne L. Viney, Kevin L. Otipoby
  • February 2020
    Bifunctional Antibody Therapy for the treatment of Type 1 Diabetes
    JDRF nPOD (Network for Pancreatic Organ Donors with Diabetes) Annual Meeting
    Daniel Rios
  • December 2019
    Antibody Engineering and Therapeutics; San Diego, CA
    Salvatore L. Alioto, Lindsay J. Edwards, Bridget M. Larkin, Angela Boisvert, Jyothsna Visweswaraiah, Joanne L. Viney, Kevin L. Otipoby, Nathan Higginson-Scott
  • November 2019
    Tissue-Specific Immunomodulation as a Novel Treatment for T1D
    JDRF New England Awards Ceremony; Boston, MA
    Daniel Rios
  • November 2019
    PT101, A Highly Selective IL-2 Mutein for AutoimmunityICMI
    The Promise of Interleukin-2 Therapy; Paris, France
    Kevin L. Otipoby, Nathan Higginson-Scott, Jo Viney
  • September 2019
    De-risking Bispecific Developability with Early Screens in Bispecific Format
    World Bispecific Summit; Waltham, MA
    Nathan Higginson-Scott
  • September 2019
    Developing targeted IL-2 mutein bispecific antibodies for gut localized immune modulation
    World Bispecific Summit; Waltham, MA
    Jyothsna Viswesvaraiah, Erik Sampson, Bridget Larkin, Tim Kiprono, Lindsay Edwards, Sal Alioto, Angela Boisvert, Jo Viney, Kevin Otipoby, Nathan Higginson-Scott
  • July 2019
    Enforcing Checkpoint Regulation: Tissue Specific PD-1 Agonism as a Novel T1D Therapeutic Approach Developing targeted IL-2 mutein
    Presentation at St. Vincent's Institute of Medical Research; Fitzroy, Australia
    Daniel Rios
  • July 2019
    Selective Expansion of Regulatory T cells by IL-2 Muteins as a Potential Treatment for IBD
    International Congress of Mucosal Immunology; Brisbane. Australia
    Daniel Rios, Erik R. Sampson, Jyothsna Visweswaraiah, Patrick Halvey,Bridget Larkin, Michael J Rowe, Rajeev K. Tyagi, Jing Li, Justin Jacobse, Margret Allaman, Keith T. Wilson, Jeremy A. Goettel, Nathan Higginson-Scott, Joanne L. Viney, Kevin L. Otipoby
  • June 2019
    Localizing Immunomodulators to Mucosal Tissues
    Federation of Clinical Immunology Societies Annual Meeting; Boston, MA
    Erik Sampson, Jyothsna Visweswaraiah, Danny Rios, Lindsay Edwards, Purvi Mande, Susmita Borthakur, Bridget Larkin, Tim Kiprono, Michael Rowe, Nathan Higginson-Scott, Kevin Otipoby, Jo Viney
  • June 2019
    Federation of Clinical Immunology Societies Annual Meeting; Boston, MA
    Lindsay J. Edwards, Daniel C. Rios, Salvatore Alioto, Bridget Larkin, Timothy Kiprono, Nathan Higginson-Scott, Joanne L. Viney, Kevin L. Otipoby
  • June 2019
    Federation of Clinical Immunology Societies Annual Meeting; Boston, MA
    Erik R. Sampson, Jyothsna Visweswaraiah, Nathan Higginson-Scott, Joanne L. Viney, Kevin L. Otipoby
  • May 2019
    Localized Immunomodulation of Regulatory T cells in the Gut
    Treg Directed Therapies Summit; Boston, MA
    Kevin Otipoby
  • April 2019
    Localized Immunomodulation for Treating Autoimmune Disease
    Quantitative Systems Pharmacology Summit; Cambridge, MA
    Nathan Higginson-Scott
  • January 2019
    Host and the Environment in IBD; Taos, NM
    Daniel C. Rios, Lindsay Edwards, Salvatore Alioto, Bridget Larkin, Timothy Kiprono, Nathan Higginson-Scott, Joanne L. Viney, Kevin L. Otipoby
Back to Top